1. Home
  2. POET vs CYRX Comparison

POET vs CYRX Comparison

Compare POET & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POET
  • CYRX
  • Stock Information
  • Founded
  • POET 1972
  • CYRX 1999
  • Country
  • POET Canada
  • CYRX United States
  • Employees
  • POET N/A
  • CYRX N/A
  • Industry
  • POET Semiconductors
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • POET Technology
  • CYRX Health Care
  • Exchange
  • POET Nasdaq
  • CYRX Nasdaq
  • Market Cap
  • POET 450.6M
  • CYRX 365.5M
  • IPO Year
  • POET N/A
  • CYRX N/A
  • Fundamental
  • Price
  • POET $6.23
  • CYRX $7.85
  • Analyst Decision
  • POET Strong Buy
  • CYRX Strong Buy
  • Analyst Count
  • POET 2
  • CYRX 10
  • Target Price
  • POET $6.25
  • CYRX $10.90
  • AVG Volume (30 Days)
  • POET 3.4M
  • CYRX 470.2K
  • Earning Date
  • POET 08-13-2025
  • CYRX 08-05-2025
  • Dividend Yield
  • POET N/A
  • CYRX N/A
  • EPS Growth
  • POET N/A
  • CYRX N/A
  • EPS
  • POET N/A
  • CYRX N/A
  • Revenue
  • POET $199,477.00
  • CYRX $232,134,000.00
  • Revenue This Year
  • POET $8,377.56
  • CYRX N/A
  • Revenue Next Year
  • POET $1,061.73
  • CYRX $9.59
  • P/E Ratio
  • POET N/A
  • CYRX N/A
  • Revenue Growth
  • POET N/A
  • CYRX 11.75
  • 52 Week Low
  • POET $2.27
  • CYRX $4.58
  • 52 Week High
  • POET $7.79
  • CYRX $9.66
  • Technical
  • Relative Strength Index (RSI)
  • POET 54.73
  • CYRX 59.21
  • Support Level
  • POET $5.94
  • CYRX $6.70
  • Resistance Level
  • POET $6.95
  • CYRX $8.45
  • Average True Range (ATR)
  • POET 0.59
  • CYRX 0.41
  • MACD
  • POET -0.09
  • CYRX 0.02
  • Stochastic Oscillator
  • POET 45.02
  • CYRX 65.71

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: